U.S.-China Venture Capital: Trends and Regulatory Challenges
DATE: Tuesday, Jan. 7
TIME: 9:00 AM – 11:00 AM PST
LOCATION: O’Melveny & Myers San Francisco
Two Embarcadero Center, 28th Floor, San Francisco, CA 94111
San Francisco, California
RSVP: Register here.
Sustained, powerful collisions between Washington and Beijing have had a reverberating impact across the business world, and especially on trade, capital flows and people. In 2018 Congress expanded the authority of the U.S. government to screen foreign investment through the Foreign Investment Risk Review Modernization Act (FIRRMA) by including venture capital (VC) and other minority portfolio stakes not previously covered. The Export Control Reform Act of (ECRA) further tightened the US export control regime, including greater oversight of “emerging” technologies.
U.S.-China VC flows have already declined since 2018, and that slowdown is likely to deepen once FIRRMA implementing regulations are rolled out through the spring of 2020. As technology competition heats up, it is more urgent than ever before for investors and companies to have access to accurate data and information about VC trends and the regulatory framework.
AmCham Shanghai is pleased to present a seminar on U.S.-China Venture Capital Trends and Regulatory Challenges from 9:00 AM to 11:00 AM, Tuesday, January 7 at the O’Melveny & Myers San Francisco offices. The session will feature a briefing on the latest trends in U.S.-China VC flows by Rhodium Group Partner and Research Coordinator at the U.S.-China Investment Project Thilo Hanemann and Rhodium Group Associate Director Adam Lysenko, an overview on U.S. regulations impacting VC flows including FIRRMA by O’Melveny & Myers Counsel David Ribner, and a panel discussion and Q&A session.